Irina V Budunova
Overview
Explore the profile of Irina V Budunova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
256
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhidkova E, Tilova L, Fetisov T, Kirsanov K, Kulikov E, Enikeev A, et al.
Int J Mol Sci
. 2024 Aug;
25(16).
PMID: 39201590
Glucocorticoids (GCs) are widely used for treating hematological malignancies despite their multiple adverse effects. The biological response to GCs relies on glucocorticoid receptor (GR) transrepression (TR) that mediates the anticancer...
2.
Dodonova S, Zhidkova E, Kryukov A, Valiev T, Kirsanov K, Kulikov E, et al.
Int J Mol Sci
. 2023 Dec;
24(24).
PMID: 38139366
This review is focused on synephrine, the principal phytochemical found in bitter orange and other medicinal plants and widely used as a dietary supplement for weight loss/body fat reduction. We...
3.
Jamerson T, Li Q, Sreeskandarajan S, Budunova I, He Z, Kang J, et al.
Front Immunol
. 2022 May;
13:845655.
PMID: 35572606
Immune-mediated skin conditions (IMSCs) are a diverse group of autoimmune diseases associated with significant disease burden. Atopic dermatitis and psoriasis are among the most common IMSCs in the United States...
4.
Lesovaya E, Chudakova D, Baida G, Zhidkova E, Kirsanov K, Yakubovskaya M, et al.
Oncotarget
. 2022 Feb;
13:408-424.
PMID: 35198100
Glucocorticoids (Gcs) are widely used to treat inflammatory diseases and hematological malignancies, and despite the introduction of novel anti-inflammatory and anti-cancer biologics, the use of inexpensive and effective Gcs is...
5.
Gasparian A, Guryanova O, Chebotaev D, Shishkin A, Yemelyanov A, Budunova I
Cell Cycle
. 2009 Apr;
8(10):1559-66.
PMID: 19372735
Nuclear factorkappaB (NFkappaB) plays a critical role in cancer development and progression. Thus, the NFkappaB signaling pathway provides important targets for cancer chemoprevention and anticancer chemotherapy. The central steps in...
6.
Chebotaev D, Yemelyanov A, Lavker R, Budunova I
J Invest Dermatol
. 2007 Jul;
127(12):2749-58.
PMID: 17657244
One of the major adverse effects of glucocorticoid therapy is cutaneous atrophy, often followed by the development of resistance to steroids. It is accepted that epithelial stem cells (SCs) located...
7.
Budunova I, Kowalczyk D, Perez P, Yao Y, Jorcano J, Slaga T
Oncogene
. 2003 May;
22(21):3279-87.
PMID: 12761498
Glucocorticoids are effective inhibitors of epidermal proliferation and skin tumorigenesis. Glucocorticoids affect cellular functions via glucocorticoid receptor (GR), a well-known transcription factor. Recently, we generated skin-targeted transgenic mice overexpressing GR...
8.
Gasparian A, Yao Y, Lu J, Yemelyanov A, Lyakh L, Slaga T, et al.
Mol Cancer Ther
. 2002 Dec;
1(12):1079-87.
PMID: 12481431
Selenium compounds are potential chemopreventive agents for prostate cancer. There are several proposed mechanisms for their anticancer effect, including enhanced apoptosis of transformed cells. Because the transcription factor nuclear factor-kappa...
9.
Gasparian A, Yao Y, Kowalczyk D, Lyakh L, Karseladze A, Slaga T, et al.
J Cell Sci
. 2002 Jan;
115(Pt 1):141-51.
PMID: 11801732
Rel/NF-kappaB transcription factors are implicated in the control of cell proliferation, apoptosis and transformation. The key to NF-kappaB regulation is the inhibitory IkappaB proteins. During response to diverse stimuli, IkappaBs...
10.
Segrelles C, Ruiz S, Perez P, Murga C, Santos M, Budunova I, et al.
Oncogene
. 2002 Jan;
21(1):53-64.
PMID: 11791176
The mouse skin carcinogenesis protocol is a unique model for understanding the molecular events leading to oncogenic transformation. Mutations in the Ha-ras gene, and the presence of functional cyclin D1...